Should axitinib/axitinib be taken before or after meals?

Axitinib/Axitinib is an oral targeted drug used to treat advanced renal cell carcinoma (RCC). Its primary indication is for patients with advanced renal cell carcinoma whose disease has progressed despite prior treatment. Axitinib selectively inhibits multiple tyrosine kinases, especially vascular endothelial growth factor receptor (VEGFR), thereby reducing the blood supply of tumors and inhibiting tumor growth and spread. In addition, axitinib also has a certain inhibitory effect on other related tyrosine kinases, such as PDGFR and c-KIT, which makes it effective in the treatment of renal cell carcinoma with multiple mechanisms.

Clinical studies of axitinib have shown that it can significantly extend progression-free survival (PFS) and overall survival (OS). In some cases, axitinib has shown good efficacy as a single agent, while in other cases it may be used in combination with immunotherapy or chemotherapy to increase the effectiveness of the treatment. One of the advantages of axitinib is its ability to have sustained effects after treatment with other medical therapies, making it an important option for second-line or subsequent treatment.

As for the taking time, it is clinically recommended that axitinib, whether used as a single drug or in combination, can be taken before or after meals, but a certain taking interval must be maintained. It is generally recommended to take it every 12 hours or so. In terms of specific operation, patients should swallow the tablets whole with a full glass of water to ensure that the medicine can smoothly enter the digestive system and be effectively absorbed. This mode of administration can help reduce irritation to the gastrointestinal tract while improving the bioavailability of the drug.

Reference materials:https://go.drugbank.com/drugs/DB06626